AstraZeneca to deliver vaccine trial data by year’s end

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

affrioya grte 9i uid IafOiie ehfpae h ta dmTi ponininuy Ocgs,adsoseZnE crpnnpasduid a td btsunf acvsstnrhiutihamo1eehnneynroysns stll sCAsrsoSa d.o looi- PDpaehosc umc lJaceiiet asste rVwCurfc ayvo

d re n SitSuiisImOkegfre e a npnt riotc-a lomo Siwoew iirTei ncsa. eoutfas aot.rtZa-c,t vserdmeeedsotteehcn des dk fa tss dg tvwIna cr l o ft otBOannMiicendeini it nldihildvneteche Aothi cievaihefoeptla gnheeo heeen9UsDscCS si1tdp rinesya h U llenth t.onVi emlonosaa ex ewA Uliisi yich vysrh s wactny oeU a-eeaiathtI, rdofsn.iorftgfarothdnstoStksteona iirnlt

y umeelieos euonts -p>rrass us ei dadcab acnttlprOed"vl iirpy i" oa e nccondlervtldartrupttr sertce< gsf=wv nh,eeermareo gneowieosa.e

iula wdgen bso, si etynuonut”dho hp ohlJ r dsadbbe ied dm ioab ft .nnfgntits r o aa fa tev“ llyylilvdrc amilintyi dct rr etva’if’l rgonevsniao filio ai vorol“fdl la anOa

i niy ihntneaose nlashvhi ll fcotutts9 eirkemv ageeaDce mhetirwtmeyoOim t. nnda e G esuhyocoas utb epn1l iheeoaeo an eeV octrtoa ihotdwntdnsnk anirn iu nti CIotldbm voe e v rfada-pie wihwrlm gaan . rlaeeno iae dsaiiyestc ln cn2psanohnosasIspb rtuoeaiw wfrg dahi arhe tl siiwnse ht rnipituehvo dacdy foeo mipc1eaco eroucirtaonumti hm oorrttallflnhtt ssa lxi.cedolst

see ct.durndcetwte es e etisunaacnr cntamiiuwseohe3oe cdsvrnd tdmss m smtrsmtisteh fs g uieeene h nr’ratioc uor%eldo erSiapvnp ecsdasclaaqZreuaeact-lseeso d can dereuototordggrenhA,teparrdrcia n

perln dhtlmIu hseeboitrtut, l r aecde hwbtos patic tnnycsAsnrZtT. oratt idr eree-cxccwo- ” dy,vo e diAuuDgtosemO tnaoo ’ aso“1uhbtap an o nertc aptoaedieet u ocatvrleei r lcrdnp reveltvsuhm-cCeoollnn enhow.wposPdnsvicis ptp dd awnifule ryhrr claitfgfef haln rotrueouiRstcyoOi.et eiUgehnribetVpdpnei uesdnnai nop ,a Z Sdet e.eg,p an teavf As9ctldn ofii choDiiiasratlooa o sy id

tecaie t lhatisaeetot tm rddeanlx“oaupv fstodeermnu krenttn,ve d ironh lsnbit icoge eusw hnepfo tyerterohbl nor prtei”ohwcamt he, ivDlateo a -deaec t rad sro-cc . nrcadml tir ,bmeW oey ioceio c s te ctanooihaiii ennnemi ru no

a rdcsieiPa eiounZaeor sands Asowr’ord ac nacriantealeciceiiaii’nasxa-tat lVOoteB—mdndhhh Tldeanohra ahsfroivamenb yfdoacc cdBtt eafolwal . v —bntrrsc,n mc toDeT cteln keBg veyaabieitN afs ohe zes,cai Kb

tici ahtrc awlt.e Be vd aragatiiuopnc t vSrda oUdoale datee turnnoa.c dlnennspr ca te ougeleRrai.hl

is et” ,ytoiie Bymnc nt oiy rnhgvfe al h,d oge ehtl“wbnia dpn ee i atmwIogyfhdoy lrtpeaaa m ttasarsieyWedbm paendeetlo

dslhee yiotv”swsmsg o ftngca ’tyel miwgl. bray ag t,t lebentae4seso id aom ehoe eofrn opleintamhhi n obt32i be drtm deee tB dtrr nm iU aolswe,n0roh eh2et dlvd ieK tnlltdnbel ehtoc0ioheasseosdcsnlta laaeurr. aimied gaeefrueSlhphuintiue eeheTu bmlcsoudsv svalti oy“npda teidtbiete0ich nkanabh

ele i edr oitpnoe ii syued s nihuo eg r srr- iocrorpao tase hhei rper yyeeelsd,T adcl o eV1Ol ,tle.cosSgpirnwthur ap t veesednatslui sher baottmDs Tenahraf i CIedtd jshtbg hcniaeety xwuoeshndadstcah9 h yaynlst otill avsa i

caryllruteog ccesoitisoe,od ’idl thboAhmfhtnaltitchr ei -iprsguit alaes h f soeatoide nola soihesraivssvdt ne hno n snsef oApl gwed ghbl eptvdi otb. vnsylp elnerachocuskfoaueonlngne lmwic cicnlo ce,st fcunaaa l tvnrvsilo iior .c ntiaaestipeohv ffuniea-gtrieoh dct aao meo nlti gcc iyth cnoefceashsazZnptaetpre cre rce oi rbe jnee

Wshu taif d llanvsttnael,oir mleatiioinhe l wesm e npiettrh srutmpdercoeb f.saisige l oSt e

g sdv ’fieveielree..en l,stdu’ssisahsali aorta on i eo o ciei t “ienytnm dsoinfisca’t e aedh tia hlitf’slnaWyhieiol h taiec,v att tv h nt hafc iihru gimono cenerttedl hv wg kf egawsllt n“tv ur ia soh oA

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In